Munafa Stock Market Course + Intraday & FNO calls 
Myriad Genetics (MYGN) Technical (Analysis) Reports Myriad Genetics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Myriad Genetics (MYGN)
Technical Analysis Report for NASDAQ stock MYGN Myriad Genetics. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MYGN Myriad Genetics then click here. or read Experts views on Myriad Genetics or Forecast & share price targets of Myriad Genetics
Myriad Genetics Opened at 5.06 and Closed at: 5.01, which is 7.98% of previous session's close. It moved within a range of 4.68 and 5.17
The session was a Bearish session with an average volume of 2174400, which is 1.97% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 4.6 and resistance for tomorrow is 5.09
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 4.74, 4.46 resistance for tomorrow's hourly charts is 5.23, 5.44
10 Day SMA for Myriad Genetics (MYGN) is 4.56 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Myriad Genetics (MYGN) is 4.75 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Myriad Genetics (MYGN) is 5.6 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 6.47 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Myriad Genetics is 6.07 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Myriad Genetics is at 4.75 and 200 DMA is at 6.07, while 50 DMA and 100 DMA are at 5.6 and 6.47 respectively
Myriad Genetics (MYGN) moving average of 20 SMA is at 4.75 and 20 EMA is at 4.86
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Mon Mar | 5.01 | 4.75 | 4.86 |
| 27 Fri Feb | 4.61 | 4.77 | 4.84 |
| 26 Thu Feb | 4.85 | 4.82 | 4.86 |
| 25 Wed Feb | 4.78 | 4.86 | 4.86 |
| 24 Tue Feb | 4.43 | 4.9 | 4.87 |
| 23 Mon Feb | 4.38 | 4.98 | 4.92 |
Myriad Genetics (MYGN) moving average of 50 SMA is at 5.6 and 50 EMA is at 5.45
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Mon Mar | 5.01 | 5.6 | 5.45 |
| 27 Fri Feb | 4.61 | 5.64 | 5.47 |
| 26 Thu Feb | 4.85 | 5.69 | 5.51 |
| 25 Wed Feb | 4.78 | 5.73 | 5.54 |
| 24 Tue Feb | 4.43 | 5.78 | 5.57 |
| 23 Mon Feb | 4.38 | 5.84 | 5.62 |
Myriad Genetics (MYGN) moving average of 100 SMA is at 6.47 and 100 EMA is at 6.01
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Mon Mar | 5.01 | 6.47 | 6.01 |
| 27 Fri Feb | 4.61 | 6.49 | 6.03 |
| 26 Thu Feb | 4.85 | 6.53 | 6.06 |
| 25 Wed Feb | 4.78 | 6.56 | 6.08 |
| 24 Tue Feb | 4.43 | 6.59 | 6.11 |
| 23 Mon Feb | 4.38 | 6.62 | 6.14 |
Myriad Genetics (MYGN) moving average of 200 SMA is at 6.07 and 200 EMA is at 7.56
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Mon Mar | 5.01 | 6.07 | 7.56 |
| 27 Fri Feb | 4.61 | 6.07 | 7.59 |
| 26 Thu Feb | 4.85 | 6.06 | 7.62 |
| 25 Wed Feb | 4.78 | 6.06 | 7.65 |
| 24 Tue Feb | 4.43 | 6.06 | 7.68 |
| 23 Mon Feb | 4.38 | 6.05 | 7.71 |
Myriad Genetics has performed better than Xeris Pharmaceuticals in short term. Holding Myriad Genetics could be a better choice for now!
Theravance Biopharma has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Theravance Biopharma, about 0.98% more returns!
Myriad Genetics has performed better than Repligen Corporation in short term. Holding Myriad Genetics could be a better choice for now!
Oncolytics Biotech has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 22.09% more returns!
Nature S has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Nature S, about 13.72% more returns!
Macrogenics Inc has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Macrogenics Inc, about 17.04% more returns!
Kodiak Sciences has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Kodiak Sciences, about 20.04% more returns!
Myriad Genetics has performed better than Aclaris Therapeutics in short term. Holding Myriad Genetics could be a better choice for now!
Myriad Genetics has performed better than Array Biopharma in short term. Holding Myriad Genetics could be a better choice for now!
Arvinas Inc has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Arvinas Inc, about 4.28% more returns!
Anavex Life has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Anavex Life, about 9.37% more returns!
Cellectis S has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Cellectis S, about 13.83% more returns!
Myriad Genetics has performed better than Champions Oncology in short term. Holding Myriad Genetics could be a better choice for now!
Cytokinetics Incorporated has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 1.08% more returns!
Dariohealth Corp has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Dariohealth Corp, about 4.44% more returns!
National Vision has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in National Vision, about 4.64% more returns!
Myriad Genetics has performed better than Guardant Health in short term. Holding Myriad Genetics could be a better choice for now!
Myriad Genetics has performed better than Gossamer Bio in short term. Holding Myriad Genetics could be a better choice for now!
Immucell Corporation has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Immucell Corporation, about 18.17% more returns!
Myriad Genetics Technical analysis of indicators
Price action analysis of Myriad Genetics (MYGN) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Myriad Genetics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Myriad Genetics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Myriad Genetics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Myriad Genetics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Myriad Genetics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.56 and Myriad Genetics MYGN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Myriad Genetics MYGN stock. Volume based technical analysis of Myriad Genetics MYGN stock is negative.
Myriad Genetics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock MYGN Myriad Genetics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MYGN Experts View which covers a lot of information including buying and selling signals
MYGN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Myriad Genetics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Myriad Genetics (MYGN) Technical (Analysis) Reports Myriad Genetics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
